EP0496841B1 - Equipment to inactivate matrix at the fluidization therapy - Google Patents
Equipment to inactivate matrix at the fluidization therapy Download PDFInfo
- Publication number
- EP0496841B1 EP0496841B1 EP91909550A EP91909550A EP0496841B1 EP 0496841 B1 EP0496841 B1 EP 0496841B1 EP 91909550 A EP91909550 A EP 91909550A EP 91909550 A EP91909550 A EP 91909550A EP 0496841 B1 EP0496841 B1 EP 0496841B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- chamber
- air
- support basin
- pressure
- evaporator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
- A61G7/05—Parts, details or accessories of beds
- A61G7/057—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor
- A61G7/05738—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with fluid-like particles, e.g. sand, mud, seeds, gel, beads
- A61G7/05746—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with fluid-like particles, e.g. sand, mud, seeds, gel, beads fluidised by air flow
Definitions
- the invention relates to a system for extracting moisture and fluid from one or more bodies, comprising a support basin accommodating moisture absorbing beads, a pressure chamber in air communication with the support basin, an air supply system for supplying air to the pressure chamber, and an evaporator chamber interconnected in the air supply path for extracting moisture from the supplied air.
- the system known from EP-A-0332242 comprises a support basin, in which beads are accommodated.
- a pressure is built up in a pressure chamber in communication with said support basin.
- the pressure chamber is connected to an air supply system.
- the moisture in the supplied air is removed by an evaporated chamber, in which an evaporator is arranged for lowering the temperature of the supplied air such that vapour droplets results.
- the vapour droplets are collected in a cabinet part provided with a heating member for evaporating the vapour droplets. Then the evaporated droplets are removed into the ambient air.
- This invention has the object to provide a system as mentioned above, by which the therapy is completely excessible to all parts of the world, thus also those with a high humidity degree and temperature. Consequently, it is necessary to reach a development, by which a continuous dehydration system will be present, so that under all climato-logical circumstances, a relative humidity degree of the floatation medium of less than 40% is reached.
- the system is not being applied to therapeutical purposes only, but can also be used for industrial and/or agrarian products.
- the principal aim, however, is to treat patients with severe tissue deformation in the gradation from excematic to gangrenous deformation, therapeutically and sterile, without the risk of contamination or cossinfection.
- the above-mentioned aim is achieved in that the evaporator chamber is in communication with a depression chamber through a reference leak.
- the optimum therapeutical depth by means of this system is reached at indication of burns 1-3 degrees, skin grafts and autografts, intensive and coronary care units, atrophy, geriatrics and many other applications, by which very vulnerable tissue is involved.
- the system is based on the principle, by which the entering air, as well as the vapour tension coming from the absorbing microspheres, will extracted from moisture continuously. Owing to this, an air entrance will occur, which is ⁇ RH 40% at a temperature adjustable from 26°C (lower than the body temperature) to 38°C (higher than the body temperature), independent from the ambient temperature.
- the viscosity is, also because of the low sg of the microspheres, 1.2 and brought in a fluidized state that could be compared with dry water with a RH ⁇ 40%.
- the body in its shape will be covered almost completely by the microspheres, which will benefit the therapy, also because of the subcapillary pressure of ⁇ 8mm/HG and the bubbling effect of the fluidized mass.
- the dissipated heat from the condensing unit will be utilized at the demand for heating of the flotation medium, so that a recirculation of the dissipated heat will hardly influence the ambient temperature.
- all moisture which will be extracted from the surroundings as well as the contents of the equipment will be recirculated into the ambient, in this manner making the atmosphere where the patient is being treated, pleasant, as a result of a higher humidity. Also the ambient temperature will hardly increase.
- the equipment of the invention could be devided into three main components:
- the operation of the invention is based on the following principle: (see figure 1).
- the ambient air will, after passing the dustfilter F1, pass the evaporator F2. Since the evaporator is brought to a temperature of 5°C, water-particles will be precipitated on the evaporator and will condensate.
- the evaporator chamber F2 is connected with the vacuum chamber F3 by means of a reference leak.
- the vacuum chamber F3 is connected to a vacuum pump or other venturi mechanism, in order to reach the desired underpressure. Causing an average vacuum pressure of 0,1mm/H2O, the boilingpoint of the water will be lowered and atomized again into the ambient.
- the air from which the water-particles have been extracted will be carried to a twostage air compressor F4, where it will reach a pressure of 500mm/H2O under the fluidization compartment as installed in F5.
- the hygrostat which has been installed will deactivate the condensing unit and evaporator, after the flotation material (microspheres) has reached the relative humidity degree of 35% (constant dehydration mode).
- the fluidization pressure of 500mm/H2O is enough to "boil" the mass ( ⁇ 550 kg microspheres) in the basin F5, with a viscosity of 1.0-1.2.
- basin F5 is adjustable in height from 65-85cm or from 80-100cm, measured from the floor surface, by means of an electric- or otherwise applied lifting system.
- the therapeutical basin is equipped with a molecular polyethylene fluidization sheet with a surface permeability of 5-20 ⁇ and a pressure drop of 20.5mBar (see figure 2 drawing C).
- a molecular polyethylene fluidization sheet with a surface permeability of 5-20 ⁇ and a pressure drop of 20.5mBar (see figure 2 drawing C).
- an equal and smooth fluidization is only possible at an absolute horizontal installation of the unit (see figure 2 drawing B).
- the fluidization will be equally shifted in a varied liquid and solid mass of the microspheres. With this not only an enclosure of the tissue as well as the body is reached, but a petrissage therapy will take effect, which will stimulate the circulation of the blood and reduce the pains, also as a result of the dehydration system.
- the modulating rotation system of the basin is connected to the existing lifting system and can be adjusted in time values from 10-60 minutes by means of an electronic control.
- the basin is held in a horizontal position of 90° (see figure 2 drawing B).
- the carrying profile has been provided with a mechanical level adjustment (see figure 3 part A). With this is achieved that the fluidization pressure measured on each part of the body, will remain constant.
- the pulse therapy is built in as standard equipment, in order to eliminate sliding forces and traction formation as much as possible.
- the flotation material By reducing the fluidization pressure to the critical value of 250mm/H2O, the flotation material (microspheres) will remain air permeable and "mould" the body of the patient in a firm shape. By reducing the volume of the air compressor to 80M3 per hour, a reduction of the working pressure will be achieved. The temperature control as well as drain of moisture from the body will remain active. The electronic adjustment of the pulse therapy can be controlled in period intervals of 1-10 minutes passive and 1-10 seconds active.
Landscapes
- Health & Medical Sciences (AREA)
- Nursing (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Devices For Medical Bathing And Washing (AREA)
Abstract
Description
- The invention relates to a system for extracting moisture and fluid from one or more bodies, comprising a support basin accommodating moisture absorbing beads, a pressure chamber in air communication with the support basin, an air supply system for supplying air to the pressure chamber, and an evaporator chamber interconnected in the air supply path for extracting moisture from the supplied air.
- The inventor has studied the above theme and improve the fluidization therapy as brought on the healthcare market in 1986/1987 and at this moment introduced as "Redactron Fluidized Therapy 002A", in which the teaching of EP-A-0332242 of 29 March 1988 is incorporated. In this way it is already possible to extract moisture from one or more bodies.
- The system known from EP-A-0332242 comprises a support basin, in which beads are accommodated. In order to fluidize the beads in said support basin, a pressure is built up in a pressure chamber in communication with said support basin. For this purpose the pressure chamber is connected to an air supply system. The moisture in the supplied air is removed by an evaporated chamber, in which an evaporator is arranged for lowering the temperature of the supplied air such that vapour droplets results. The vapour droplets are collected in a cabinet part provided with a heating member for evaporating the vapour droplets. Then the evaporated droplets are removed into the ambient air.
- This invention has the object to provide a system as mentioned above, by which the therapy is completely excessible to all parts of the world, thus also those with a high humidity degree and temperature. Consequently, it is necessary to reach a development, by which a continuous dehydration system will be present, so that under all climato-logical circumstances, a relative humidity degree of the floatation medium of less than 40% is reached.
- The system is not being applied to therapeutical purposes only, but can also be used for industrial and/or agrarian products. The principal aim, however, is to treat patients with severe tissue deformation in the gradation from excematic to gangrenous deformation, therapeutically and sterile, without the risk of contamination or cossinfection.
- According to the invention the above-mentioned aim is achieved in that the evaporator chamber is in communication with a depression chamber through a reference leak.
- The optimum therapeutical depth by means of this system, is reached at indication of burns 1-3 degrees, skin grafts and autografts, intensive and coronary care units, atrophy, geriatrics and many other applications, by which very vulnerable tissue is involved.
- The system is based on the principle, by which the entering air, as well as the vapour tension coming from the absorbing microspheres, will extracted from moisture continuously. Owing to this, an air entrance will occur, which is < RH 40% at a temperature adjustable from 26°C (lower than the body temperature) to 38°C (higher than the body temperature), independent from the ambient temperature. The viscosity is, also because of the low sg of the microspheres, 1.2 and brought in a fluidized state that could be compared with dry water with a RH < 40%. The body in its shape, will be covered almost completely by the microspheres, which will benefit the therapy, also because of the subcapillary pressure of ± 8mm/HG and the bubbling effect of the fluidized mass. The dissipated heat from the condensing unit will be utilized at the demand for heating of the flotation medium, so that a recirculation of the dissipated heat will hardly influence the ambient temperature. At the same time, all moisture which will be extracted from the surroundings as well as the contents of the equipment, will be recirculated into the ambient, in this manner making the atmosphere where the patient is being treated, pleasant, as a result of a higher humidity. Also the ambient temperature will hardly increase.
- The equipment of the invention could be devided into three main components:
- 1. An evaporator with a constant temperature of 5°C, connected to a vacuum condensing chamber and atomizer. The evaporator is controlled by a condensing unit consisting of a compressor part with a direct expansion, modulating and a tracking pressure, depending on the ambient temperature of 17°C to a maximum of 45°C. As coolant freon or substitute is applied.
- 2. The air chamber, supplied with a twostage compressor, to achieve the fluidization pressure (preferential pressure P=500mm/H2O). In the suctionline an airvalve has been adapted, which is controlled by a thermostatic device and is connected to the condensing chamber.
- 3. Therapeutical basin filled with 550 kg microspheres, in which the patient is treated and which is covered by a loose stretched polycon filtersheet or other comparable material with a permeability of 35 micron. The therapeutical basin can also be filled with microspheres which have a hollow structure and if possible a diameter of 100µ and larger. By means of pressure adjustments with a differential pressure of at least P=200mm/H2O, an equivalent viscosity of the flotation medium will be obtained. The use of the microspheres with a hollow structure has as great benefit that the total weight of the microspheres will be decreased with a
factor 5. Owing to this, the fluidization unit can be installed on wooden floors without support, consequently accessible for installation in every imaginable space. - The operation of the invention is based on the following principle: (see figure 1). The ambient air will, after passing the dustfilter F1, pass the evaporator F2. Since the evaporator is brought to a temperature of 5°C, water-particles will be precipitated on the evaporator and will condensate. The evaporator chamber F2 is connected with the vacuum chamber F3 by means of a reference leak. The vacuum chamber F3 is connected to a vacuum pump or other venturi mechanism, in order to reach the desired underpressure. Causing an average vacuum pressure of 0,1mm/H2O, the boilingpoint of the water will be lowered and atomized again into the ambient.
- After the air treatment, the air from which the water-particles have been extracted, will be carried to a twostage air compressor F4, where it will reach a pressure of 500mm/H2O under the fluidization compartment as installed in F5. In this fluidization compartment the hygrostat which has been installed, will deactivate the condensing unit and evaporator, after the flotation material (microspheres) has reached the relative humidity degree of 35% (constant dehydration mode). The fluidization pressure of 500mm/H2O is enough to "boil" the mass (± 550 kg microspheres) in the basin F5, with a viscosity of 1.0-1.2.
- In case moisture is inserted in the absorbing microspheres, a vapour pressure will be created to the evaporator F2, which has a temperature of 5°C. This as a result of the second law of the thermodynamics. Here the vapour pressure will again condensate in waterparticles and drained into the vacuum chamber. At the demand for heating of the flotation medium, the airstream will be a mixture of the ambient air together with the condensing dissipation by means of airvalve F7, which will be opened. With this a recirculation of the absorbed and dissipated ambient heat is reached.
- In order to simplify the nursing actions and to improve the patient's comfort, basin F5 is adjustable in height from 65-85cm or from 80-100cm, measured from the floor surface, by means of an electric- or otherwise applied lifting system.
- The therapeutical basin is equipped with a molecular polyethylene fluidization sheet with a surface permeability of 5-20µ and a pressure drop of 20.5mBar (see figure 2 drawing C). Owing to the stiff behaviour of the polyethylene, an equal and smooth fluidization is only possible at an absolute horizontal installation of the unit (see figure 2 drawing B). By modulating the installation of the basin within 4 degrees with regard to the horizontal situation (see figure 2 drawing A), the fluidization will be equally shifted in a varied liquid and solid mass of the microspheres. With this not only an enclosure of the tissue as well as the body is reached, but a petrissage therapy will take effect, which will stimulate the circulation of the blood and reduce the pains, also as a result of the dehydration system.
- The modulating rotation system of the basin is connected to the existing lifting system and can be adjusted in time values from 10-60 minutes by means of an electronic control. At a constant fluidization therapy, the basin is held in a horizontal position of 90° (see figure 2 drawing B).
- By applying the molecular polyethylene fluidization board with a stiff behaviour, the carrying profile has been provided with a mechanical level adjustment (see figure 3 part A). With this is achieved that the fluidization pressure measured on each part of the body, will remain constant.
- The pulse therapy is built in as standard equipment, in order to eliminate sliding forces and traction formation as much as possible.
- By reducing the fluidization pressure to the critical value of 250mm/H2O, the flotation material (microspheres) will remain air permeable and "mould" the body of the patient in a firm shape. By reducing the volume of the air compressor to 80M3 per hour, a reduction of the working pressure will be achieved. The temperature control as well as drain of moisture from the body will remain active. The electronic adjustment of the pulse therapy can be controlled in period intervals of 1-10 minutes passive and 1-10 seconds active.
Claims (12)
- System for extracting moisture and fluid from one or more bodies, comprising a support basin (F5) accommodating moisture absorbing beads, a pressure chamber in air communication with the support basin, an air supply system (F1, F4) for supplying air to the pressure chamber, and an evaporator chamber (F2) interconnected in the air supply path for extracting moisture from the supplied air, characterized in that the evaporator chamber (F2) is in communication with a depression chamber (F3) through a reference leak.
- System according to claim 1, characterized in that the depression chamber is connected to a vacuum pump.
- System according to claim 1, characterized in that the depression chamber is connected to a venturi mechanism.
- System according to claim 1, 2 or 3, wherein the evaporator in the evaporator chamber (F2) is controlled by a condensing unit consisting of a compressor (F8) and a condensor (F9) and wherein the compressor is controlled by a hygrostat arranged in the pressure chamber.
- System according to claim 4, wherein the condensor is accommodated in a housing connected to the supply system by means of ducts and an air valve (F7) interconnected therein.
- System according to one of the previous claims, wherein the beads are hollow microspheres, with a diameter preferable larger than 100µ and a unit specified gravity g/cm3 comparable to bulk density lower than 2.2 passive (not fluidizing).
- System according to one of the claims 1-5, wherein the beads are not solid, to achieve a lower unit sg per mass, comparable to bulk density valume increasing 1-1.2 g/cm3 active (fluidizing).
- System according to one of the preceding claims, wherein the support basin, covered by a permeable sheet for the body from which moisture should be extracted, is provided with an electric or other lifting system, in order to vary the lying level to the floor surface from 65-85 cm or from 80-100 cm.
- System according to one of the preceding claims, wherein the application will not only be limited to medical/therapeutical treatments, but will also be applied to bedsystems for domestic use.
- System according to one of the preceding claims, wherein the support basin can be modulated at an angle of 4° with regard to the horizontal level, in order to achieve an intermittently enclosure of body and tissue.
- System according to one of the preceding claims, wherein the fluidization pressure in the support basin can be reduced through an electronic a-synchronous multivibrator included in the air supply system (F1, F4) (microprocessing controller), to eliminate sliding forces and to mobilize the patient (pulse therapy mode).
- System according to one of the preceding claims, wherein the carrying profile of the support basin has been provided with a mechanical level adjustment, in order to keep the smooth fluidization pressure on the body of a patient as constant as possible.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9001211 | 1990-05-28 | ||
NL9001211A NL9001211A (en) | 1990-05-28 | 1990-05-28 | EQUIPMENT FOR INACTIVATING NUTRIENTS IN THE FLUIDIZATION THERAPY. |
PCT/NL1991/000078 WO1991018578A1 (en) | 1990-05-28 | 1991-05-07 | Equipment to inactivate matrix at the fluidization therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0496841A1 EP0496841A1 (en) | 1992-08-05 |
EP0496841B1 true EP0496841B1 (en) | 1997-12-29 |
Family
ID=19857152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP91909550A Expired - Lifetime EP0496841B1 (en) | 1990-05-28 | 1991-05-07 | Equipment to inactivate matrix at the fluidization therapy |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0496841B1 (en) |
AT (1) | ATE161415T1 (en) |
DE (1) | DE69128523T2 (en) |
ES (1) | ES2110439T3 (en) |
NL (1) | NL9001211A (en) |
WO (1) | WO1991018578A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5402542A (en) * | 1993-04-22 | 1995-04-04 | Ssi Medical Services, Inc. | Fluidized patient support with improved temperature control |
US6073289A (en) | 1997-12-18 | 2000-06-13 | Hill-Rom, Inc. | Air fluidized bed |
US6158070A (en) * | 1999-08-27 | 2000-12-12 | Hill-Rom, Inc. | Coverlet for an air bed |
US9763842B2 (en) * | 2012-06-27 | 2017-09-19 | Hill-Rom Services, Inc. | Fluidizable bed with lateral rotation capability and method of operation therefor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3428973A (en) * | 1966-03-17 | 1969-02-25 | Thomas S Hargest | Fluidized supporting apparatus |
CH449848A (en) * | 1967-05-09 | 1968-01-15 | J Werding Winfried | Automatic swing bed |
JPS59218151A (en) * | 1983-05-27 | 1984-12-08 | 富士電機株式会社 | Lift controller of flowing type bed |
JPS59218152A (en) * | 1983-05-27 | 1984-12-08 | 富士電機株式会社 | Hardness controller of flow bed |
JPS61290953A (en) * | 1985-06-19 | 1986-12-20 | 富士電機株式会社 | Body support |
US4768250A (en) * | 1985-07-30 | 1988-09-06 | Fuji Electric Co., Ltd. | Fluidized bead bed |
NL8800792A (en) * | 1988-03-29 | 1989-10-16 | Redactron Bv | METHOD AND APPARATUS FOR EXTRACTING MOISTURE FROM ONE OR MORE BODIES |
-
1990
- 1990-05-28 NL NL9001211A patent/NL9001211A/en not_active Application Discontinuation
-
1991
- 1991-05-07 EP EP91909550A patent/EP0496841B1/en not_active Expired - Lifetime
- 1991-05-07 WO PCT/NL1991/000078 patent/WO1991018578A1/en active IP Right Grant
- 1991-05-07 ES ES91909550T patent/ES2110439T3/en not_active Expired - Lifetime
- 1991-05-07 DE DE69128523T patent/DE69128523T2/en not_active Expired - Fee Related
- 1991-05-07 AT AT91909550T patent/ATE161415T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1991018578A1 (en) | 1991-12-12 |
ES2110439T3 (en) | 1998-02-16 |
EP0496841A1 (en) | 1992-08-05 |
DE69128523T2 (en) | 1998-04-16 |
NL9001211A (en) | 1991-12-16 |
DE69128523D1 (en) | 1998-02-05 |
ATE161415T1 (en) | 1998-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1336534C (en) | Method and device for abstracting moisture and fluid from one or more bodies | |
US3511162A (en) | Apparatus and method for isolating a patient zone | |
US8241258B2 (en) | Wound treatment system and method of use | |
EP0496841B1 (en) | Equipment to inactivate matrix at the fluidization therapy | |
US5179943A (en) | Medical apparatus using ozone gas | |
CN104323897A (en) | Medical suspending bed with double constant laminar flows | |
US3866612A (en) | Apparatus for treatment of skin lesions | |
KR101824143B1 (en) | Ethylene oxide gas sterilizer | |
CN208541519U (en) | A kind of novel general surgery's workbench | |
US5206896A (en) | Immobilization of domestic animals in a bed of fluidizable solid particles | |
CN2554577Y (en) | Wardrobe with high-efficient, disinfection, de-peculiar-smell drying device for quilt and pillow | |
CN215021914U (en) | Sand suspension treatment bed with red light | |
CN204219214U (en) | Two permanent laminar flow is medical suspension bed | |
SE9100174L (en) | STERILATION PROCEDURE AND DEVICE | |
KR102233717B1 (en) | Apparatus for disinfecting shoes | |
CN107777054A (en) | A kind of multi-functional mechanical apparatus box | |
CN215651605U (en) | Temperature maintaining device after amputated limb replantation | |
CN109481111A (en) | A kind of burn laminar flow therapy apparatus | |
JPS6058369B2 (en) | Temperature and humidity control equipment for operating rooms, etc. | |
JPH01259863A (en) | Beauty room | |
CN112274415A (en) | Traditional chinese medicine fumigation and washing equipment | |
GB2022399A (en) | Racking systems | |
WO2018179053A1 (en) | Enzyme water production method and enzyme water production device | |
CN111227525A (en) | Sterilizing shoe cabinet with dehumidifying device | |
US20120110743A1 (en) | Fluidizable medium support bed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE ES FR GB IT LI NL |
|
17P | Request for examination filed |
Effective date: 19920610 |
|
17Q | First examination report despatched |
Effective date: 19940824 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: REDITAC B.V. |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: REDITAC B.V. |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE ES FR GB IT LI NL |
|
REF | Corresponds to: |
Ref document number: 161415 Country of ref document: AT Date of ref document: 19980115 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: KELLER & PARTNER PATENTANWAELTE AG Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69128523 Country of ref document: DE Date of ref document: 19980205 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2110439 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
RIN2 | Information on inventor provided after grant (corrected) |
Free format text: RYHINER, VICTOR, GEORGE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20020520 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20020815 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20020819 Year of fee payment: 12 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030507 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030531 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030531 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20030508 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20060518 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20060523 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20060531 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20060707 Year of fee payment: 16 |
|
BERE | Be: lapsed |
Owner name: *REDITAC B.V. Effective date: 20070531 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20080131 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070531 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20080331 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20080520 Year of fee payment: 18 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070507 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20090507 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20091201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20090507 |